Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult‐to‐Treat Migraine Headaches

OBJECTIVE: To understand the efficacy of zolmitriptan applied with Adhesive Dermally Applied Microarray (ADAM) in treating types of migraine (those with severe headache pain, the presence of nausea, treatment ≥2 hours after migraine onset, or migraine present upon awakening) that are historically co...

Descripción completa

Detalles Bibliográficos
Autores principales: Tepper, Stewart J., Dodick, David W., Schmidt, Peter C., Kellerman, Donald J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590125/
https://www.ncbi.nlm.nih.gov/pubmed/30698272
http://dx.doi.org/10.1111/head.13482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590125/
https://www.ncbi.nlm.nih.gov/pubmed/30698272
http://dx.doi.org/10.1111/head.13482

Ejemplares similares